Pharma Commercialization Solutions: IntegriChain Exemplifies the Opportunity

HCLS Article Integrichain Header

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Managing Director

Profile

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0003 AndreyDvorkin

Director

The outsourced pharma commercialization solutions segment is a dynamic space continually creating new opportunities for M&A investors.

Pharma Commercialization Solutions: Shifting Tech & Data Needs

IntegriChain Acquired by Nordic Capital   

5991 IntegriChain NT

Mergers & Acquisitions

The CM Group

United States

5679 The CM Group

Harris Williams advised Medical Knowledge Group, a portfolio company of Court Square, on its sale to Novo Holdings. Medical Knowledge Group is an analytics-driven drug commercialization platform serving the biopharmaceutical industry.

Medical Knowledge Group

5490_medical_knowledge_group_mkg.png

An analytics-driven commercialization solutions provider for biopharmaceutical customers 
 
 A portfolio company of Windrose Health Investors 
 
 Has been recapitalized by Court Square Capital Partners

medical-knowledge-group-2.png

Harris Williams advised Kantar Health, a division of Kantar and portfolio company of Bain Capital Private Equity, on its sale to Cerner Corporation (NASDAQ: CERN ) . Kantar Health is a leading global healthcare data, analytics and research provider.

Kantar Health

4992kantar-health.png

Harris Williams advised Knox Lane, a leading middle market investment firm focused on the consumer and services sectors, on its strategic investment in Fingerpaint, a leading provider of analytics-enabled marketing solutions to biopharmaceutical customers.

Fingerpaint

5253fingerprint-marketing-project-charlie.png

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Select Activity

Return on Innovation, Part 1: Commercialization Services

Return on Innovation: An Eight-Part Series

Outsourced Pharma Services & Pharma Technology Q4 2023

Outsourced Pharma Services: Three CEOs Talk Trends and M&A

Select Activity

Related Insights

Return on Innovation, Part 1: Commercialization Services

Return on Innovation: An Eight-Part Series

Outsourced Pharma Services & Pharma Technology Q4 2023

Outsourced Pharma Services: Three CEOs Talk Trends and M&A